Drug profile · INN
methylnaltrexone bromide
RELISTOR
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
methylnaltrexone bromide (RELISTOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN methylnaltrexone bromide
Brand RELISTOR
Route SUBCUTANEOUS
Formulation SOLUTION
ATC code A06AH01
Frequently asked questions
What is methylnaltrexone bromide?
methylnaltrexone bromide (RELISTOR) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for methylnaltrexone bromide?
RELISTOR is a marketed brand name for methylnaltrexone bromide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of methylnaltrexone bromide?
methylnaltrexone bromide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.